Substance
LIFILEUCEL
Global reference: every product and company linked to this substance.
- cas: 2306267-74-1
- ncit: C120552
- unii: R0835E18NH
AMTAGVI · lifileucel [INN] · LIFILEUCEL [USAN] · Lifileucel [WHO-DD] · LN 145 [WHO-DD] · LN-144 · LN-145
Revenue by product (1)
| Company | Product | Latest period | Revenue |
|---|---|---|---|
| IOVANCE BIOTHERAPEUTICS INC. COMMON STOCK | AMTAGVI | Q2 2026 | $90.7M |
A figure belongs to the product it was reported for. It is never summed across companies or across a company's products, so one substance in three products shows three figures.
Products containing this substance (1)
- AMTAGVI · IOVANCE BIOTHERAPEUTICS INC. COMMON STOCK